ClinConnect ClinConnect Logo
Search / Trial NCT05875090

Glaucoma Portugal Screening Trial

Launched by CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE · May 16, 2023

Trial Information

Current as of May 08, 2025

Enrolling by invitation

Keywords

Screening

ClinConnect Summary

Glaucoma diagnosis is currently based on opportunistic case finding, which makes the case for up to 50% of patients remaining undiagnosed. Diagnostic technology has been deemed efficient in diagnosing, but cost and (hospital) location acts as a barrier for effective screening for this asymptomatic disease with a low population-based prevalence

Portuguese National Strategy for Visual Health, published in 2018 asks for a pilot study aimed at a one-time intervention at the primary care setting at the age of 60 years to do both an optic disc analysis and an intraocular pressure (IOP) measureme...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • subjects age between 55 to 65 years old registered in the primary care area of either ACES Lisbon Norte (Lisbon arm) or in the area of ACES Alto Minho (Minho arm)
  • willingness to sign an informed consent for the screening process
  • Exclusion Criteria:
  • - none
  • Poor quality in screening image will be included in the intention to treat analysis, but excluded from the diagnostic comparator outcome.
  • Patients with a known glaucoma diagnosis will not be excluded from the screening

About Centro Hospitalar Universitário Lisboa Norte

Centro Hospitalar Universitário Lisboa Norte (CHULN) is a leading academic medical center in Portugal, dedicated to advancing healthcare through innovative clinical research. As a prominent sponsor of clinical trials, CHULN integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations that enhance patient care and contribute to medical knowledge. With a multidisciplinary team of healthcare professionals and researchers, CHULN emphasizes ethical standards and regulatory compliance in its research initiatives, aiming to improve treatment outcomes and develop new therapeutic options for a wide range of conditions.

Locations

Lisbon, , Portugal

Lisbon, , Portugal

Viana Do Castelo, , Portugal

Patients applied

0 patients applied

Trial Officials

Luis Abegão Pinto, MD, PhD

Study Chair

Centro Hospitalar Universitário Lisboa Norte

Sérgio Azevedo, MD

Study Chair

Unidade Local Saude Alto Minho

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported